FdaApplication
NDA 022021
Identifiers
- fda_app_no: NDA022021
Properties
| Property | Value |
|---|---|
| applicant_name | KING PHARMACEUTICALS INC SUB PFIZER INC |
| application_type | NDA |
| approval_date | 2007-02-27 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALTACE | RAMIPRIL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ALTACE | RAMIPRIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ALTACE | RAMIPRIL | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ALTACE | RAMIPRIL | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
4 products